Sampre Nutritions Limited (BOM:530617)
India flag India · Delayed Price · Currency is INR
4.420
+0.010 (0.23%)
At close: Nov 16, 2026

Sampre Nutritions Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
506.63433.47251.24251.47371.07231.26
Revenue Growth
48.10%72.53%-0.09%-32.23%60.46%26.83%
Gross Profit
140.41117.6921.4885.3783.2563.92
Operating Income
25.0227.12-58.3422.9222.3418.84
Net Income
27.0230.77-76.722.323.473.08
Earnings Per Share
1.912.18-5.430.080.090.16
EPS Growth
----8.89%-42.06%306.61%

Cash & Debt

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
0.520.822.322.851.260.83
Total Debt
89.74179.1169.04175167.71212.33
Net Cash (Debt)
-89.22-178.28-166.72-172.16-166.45-211.51
Net Cash Growth
------
Net Cash Per Share
-6.32-12.61-11.79-6.26-4.43-10.97

Cash Flow & CapEx

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
51.25-10.970.8539.528.7924.09
Capital Expenditures
-22.86-22.86-2.77-37.09-44.06-13.02
Free Cash Flow
28.39-33.83-1.932.44-35.2711.07
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
27.71%27.15%8.55%33.95%22.44%27.64%
Operating Margin
4.94%6.26%-23.22%9.11%6.02%8.15%
Pretax Margin
2.85%4.10%-29.95%1.94%1.13%1.61%
Profit Margin
5.33%7.10%-30.54%0.92%0.94%1.33%
FCF Margin
5.60%-7.80%-0.77%0.97%-9.51%4.79%

Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
2.3149.16-213.86180.4750.97
P/FCF Ratio
14.76--203.16-14.18
PS Ratio
0.833.491.881.971.690.68